Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates
Go back to Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates| (NASDAQ: VRDN) | Delayed: 23.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.17 | 52 Week High | $ | |||
| Open | $23.17 | 52 Week Low | $ | |||
| Day High | $23.17 | P/E | N/A | |||
| Day Low | $23.17 | EPS | $ | |||
| Volume | 132 | |||||

